ROIS global CDMO
With a history spanning 80+ years and facilities across Europe and the United States, ROIS provides the scale, expertise and reliability programs need, from late-stage development through commercial supply.


The ROIS vision
To redefine what the industry expects from a CDMO by becoming the global standard for complex injectable manufacturing through a model that combines capability and true strategic partnership, building a more reliable global supply.
FAQs
ROIS combines the scale and capabilities of a global CDMO with the responsiveness of a family-led business. Customers benefit from direct access to senior leadership, including the executive team, enabling faster decision-making, closer collaboration and long-term partnerships built around the success of every program.
ROIS operates five manufacturing sites across Europe and the United States, supporting pharmaceutical and biotechnology companies with commercial manufacturing capacity, regional expertise and reliable global supply for complex pharmaceutical products.
Quality is embedded throughout every stage of manufacturing. Established quality systems, rigorous regulatory standards and commercial approvals across more than 75 global markets help ensure every program meets the highest expectations for product quality, compliance and patient safety.
ROIS partners with pharmaceutical and biotechnology companies of all sizes to manufacture late stage clinical and commercial products. Every partnership is built around technical collaboration, manufacturing expertise and long-term supply continuity.
ROIS careers
Join a team redefining what the industry expects from a CDMO, combining technical capability with true partnership to build a more resilient global supply of life-changing medicines.
Latest news and resources
Personalized partnerships. Global reach.
Connect with the ROIS team to explore what true manufacturing partnership looks like, with a shared commitment in every program's success, at any scale.







